PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

$14.95M 2025-2026 cycle

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is a political services vendor. In the 2025-2026 cycle PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA was paid $14.95M across 6 client committees, of which $8.11M flowed through Independent Expenditures rather than direct committee payments.

○ Dormant (13mo since last)
Limited recent activity. Most recent disbursement to this vendor was 1+ years ago (May 12, 2025). Charts below reflect cycle-to-date totals; the recent windows may be sparse.

Part I Identity

Stable facts about this entity. These figures do not change as you adjust the timeframe in Part II.

Source split

$14.95M = $6.84M (Schedule B) + $8.11M (Independent Expenditures)
Schedule B
direct committee payments
$6,843,973 32 rows 45.8%
Independent Expenditures
money this entity spent supporting candidates, NOT a committee paying them
$8,108,430 71 rows 54.2%
Activity span ALL TIME
Jul 5, 2005 → May 12, 2025
spans 19.9 years
Disbursements ALL TIME
32
Schedule B + IE rows
Client committees ALL TIME
6
distinct payers

Part II Activity in selected window

One timeframe control governs all three panels below. Change it once and the trajectory, top buyers, and party breakdown all update together.

Spend trajectory

Monthly spend to this vendor over the last 12 months.

May 2023 Apr 2024
$62K across 12 months
#

Top buyers

Two views of the same data — diagram and table share the time-window control and the same top-buyers slice. Click "View all buyers in research" to drill in with the matching date range.

No buyer activity in this window.

No buyer activity in this window.

No buyer activity in this window.

No buyer activity in this window.

No buyer activity in this window.

No buyer activity in this window.

By party

Revenue by party

100% R
D · 0%
R · 100%
PartyAmount%
Democratic $0 0.00%
Republican $19,851 0.13%
Non-partisan $14,932,552 99.87%

Part III Reference tables

Full all-time and cycle-to-date data.

#

Cycle-over-cycle trajectory

2017201920202021202220232024 Q1 2017 (2016 cycle): $53KQ3 2017 (2018 cycle): $9KQ4 2017 (2018 cycle): $4KQ2 2019 (2018 cycle): $64KQ1 2020 (2020 cycle): $2KQ2 2020 (2020 cycle): $62KQ1 2021 (2020 cycle): $62KQ2 2021 (2020 cycle): $2KQ2 2022 (2022 cycle): $62KQ1 2023 (2022 cycle): $61KQ2 2023 (2022 cycle): $899Q2 2024 (2024 cycle): $61K Q1Q4Q1Q1Q2Q2Q2 $64K

current cycle earlier election cycle off-cycle year quarterly · 7 years

Per-quarter totals
Year Q Cycle Total Txns Top buyer · share Top category · share Cum. (cycle) YoY %
2017 Q1 2016 $53K 1 PHARMACEUTICAL RESEARCH AND… 100% Other / Unclassified 100% $53K
2017 Q3 2018 $9K 1 MURPHY, TIMOTHY 100% Fundraising 100% $9K
2017 Q4 2018 $4K 1 COMMON SENSE COLORADO 100% Travel & Events 100% $13K
2019 Q2 2018 $64K 2 PHARMACEUTICAL RESEARCH AND… 100% Other / Unclassified 100% $77K
2020 Q1 2020 $2K 1 PHARMACEUTICAL RESEARCH AND… 100% Other / Unclassified 100% $2K
2020 Q2 2020 $62K 2 PHARMACEUTICAL RESEARCH AND… 80% Other / Unclassified 100% $64K
2021 Q1 2020 $62K 2 PHARMACEUTICAL RESEARCH AND… 81% Other / Unclassified 100% $126K
2021 Q2 2020 $2K 1 PHARMACEUTICAL RESEARCH AND… 100% Other / Unclassified 100% $128K -97%
2022 Q2 2022 $62K 2 PHARMACEUTICAL RESEARCH AND… 81% Other / Unclassified 100% $62K -0%
2023 Q1 2022 $61K 2 PHARMACEUTICAL RESEARCH AND… 82% Other / Unclassified 100% $123K -2%
2023 Q2 2022 $899 1 PHARMACEUTICAL RESEARCH AND… 100% Other / Unclassified 100% $124K -53%
2024 Q2 2024 $61K 2 PHARMACEUTICAL RESEARCH AND… 92% Other / Unclassified 100% $61K -2%
#

Revenue by service category

No category revenue in this window.

No category revenue in this window.

No category revenue in this window.

No category revenue in this window.

No category revenue in this window.

No category revenue in this window.

Per-category breakdown · cycle-to-date
Category Total spend Txns Avg check % of total Top buyer · share Last paid
Other / Unclassified $6,831,212 30 $228K 99.8% PHARMACEUTICAL RESEARCH AND… 57% 2y ago
Fundraising $9,086 1 $9K 0.1% MURPHY, TIMOTHY 100% 8y ago
Travel & Events $3,675 1 $4K 0.1% COMMON SENSE COLORADO 100% 8y ago
#

Client retention

Sticky-relationship signal: how many clients keep coming back across cycles vs one-time buyers.

2
Anchor clients 3+ cycles
$2,927,212 · 43% of revenue
0
Repeat clients 2 cycles
$0 · 0% of revenue
4
One-time clients 1 cycle
$3,916,761 · 57% of revenue
Top 2 anchor clients · all-time
#

Geographic concentration

Where this vendor's clients are based — federal committees by state, plus implicit jurisdiction for CA and TX state filers.

State   Total spend % of revenue Clients
CA
$6,831,212 99.8% 4
PA
$9,086 0.1% 1
CO
$3,675 0.1% 1
#

Notable disbursements

5 largest all-time · 5 largest in the current cycle · 5 most recent. Each row earns its place.

Reason Date Filer Category Purpose Amount
Largest all-time 2005-07-05 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND Other / Unclassified $3,898,000
Largest all-time 2015-09-22 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. Other / Unclassified $1,105,000
Largest all-time 2015-11-03 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. Other / Unclassified $1,075,000
Largest all-time 2015-11-24 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. Other / Unclassified $115,000
Largest all-time 2019-05-06 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA IEC Other / Unclassified $62,200
Largest this cycle 2024-04-15 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA IEC Other / Unclassified $55,900
Largest this cycle 2024-04-09 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. Other / Unclassified $5,000
Recent 2023-02-21 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA IEC Other / Unclassified $50,000
Recent 2023-02-23 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. Other / Unclassified $10,900
Recent 2023-05-04 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA IEC Other / Unclassified $899
5 raw FEC name variants collapsed into this canonical entity
See all 32 disbursements →